ASSAY OF AZATHIOPRINE, 6-MERCAPTOPURINE AND A NOVEL THIOPURINE METABOLITE IN HUMAN-PLASMA

被引:42
作者
MADDOCKS, JL [1 ]
机构
[1] CARDIFF ROYAL INFIRM, KRUF INST RENAL DIS, CARDIFF, S GLAMORGAN, WALES
关键词
D O I
10.1111/j.1365-2125.1979.tb01014.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 A simple, specific assay for 6‐mercaptopurine (6‐MP) in human plasma with a sensitivity of 10 ng/ml (66 nmol/1) has been developed. 2 6‐MP was extracted directly from plasma into toluene using a novel extraction procedure. This involves conversion of 6‐MP into a phenyl mercury derivative by its reaction with phenyl mercuric acetate in alkaline plasma and extracting into toluene. Back‐extraction of the toluene layer with 0.1N HCl regenerates 6‐MP, which is then oxidised to purine‐6‐sulphonate and assayed fluorimetrically. 3 This assay has been modified to measure azathioprine and a new thiopurine metabolite in plasma. 4 In a kidney transplant patient given azathioprine, 50 mg i.v., conversion to 6‐MP was rapid and the plasma half‐life of 6‐MP was 36 min. 5 These assays are suitable for studying the pharmacokinetics of azathioprine in patients with kidney transplants. The 6‐MP assay should also prove useful for studying the pharmacokinetics of the drug in patients with leukaemia. 1979 The British Pharmacological Society
引用
收藏
页码:273 / 278
页数:6
相关论文
共 13 条
[1]   GAS-CHROMATOGRAPHIC METHOD FOR MEASURING 6-MERCAPTOPURINE IN SERUM [J].
BAILEY, DG ;
WILSON, TW ;
JOHNSON, GE .
JOURNAL OF CHROMATOGRAPHY, 1975, 111 (02) :305-311
[2]  
BRODIE BB, 1945, J BIOL CHEM, V158, P705
[3]  
CALNE R Y, 1961, Surg Forum, V12, P118
[4]  
COFFEY JJ, 1972, CANCER RES, V32, P1283
[5]  
ELION GB, 1961, CANCER CHEMOTH REP, P93
[6]   A FLUOROMETRIC METHOD FOR ESTIMATION OF 6-MERCAPTOPURINE IN SERUM [J].
FINKEL, JM .
ANALYTICAL BIOCHEMISTRY, 1967, 21 (03) :362-&
[7]  
HAMILTON L, 1954, Ann N Y Acad Sci, V60, P304
[8]  
LOO TL, 1968, CLIN PHARMACOL THER, V9, P180
[9]   SEPARATION AND DETECTION OF PICOMOLE QUANTITIES OF AZATHIOPRINE METABOLITES [J].
MADDOCKS, JL ;
DAVIDSON, GS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (04) :359-360
[10]  
MADDOCKS JL, 1975, 9TH ANN M EUR SOC CL, P10